Description
AM630 ≥90% (HPLC), 5MG
Synonym(s):
6-Iodo-2-methyl-1-[2-(4-morpholinyl)ethyl]-1H-indol-3-yl](4-methoxyphenyl)methanone, AM 630, Iodopravadoline
Empirical Formula (Hill Notation):
C23H25IN2O3
CAS Number:
164178-33-0
Molecular Weight:
504.36
MDL number:
MFCD01861183
PubChem Substance ID:
329825332
NACRES:
NA.77
Quality Level
100
assay
≥90% (HPLC)
form
powder
storage condition
desiccated
color
white to beige
solubility
DMSO: >5 mg/mL
storage temp.
2-8°C
SMILES string
COc1ccc(cc1)C(=O)c2c(C)n(CCN3CCOCC3)c4cc(I)ccc24
InChI
1S/C23H25IN2O3/c1-16-22(23(27)17-3-6-19(28-2)7-4-17)20-8-5-18(24)15-21(20)26(16)10-9-25-11-13-29-14-12-25/h3-8,15H,9-14H2,1-2H3
InChI key
JHOTYHDSLIUKCJ-UHFFFAOYSA-N
Application
AM630 has been used:
- as a cannabinoid 2(CB2) inhibitor to study the analgesic effect exerted by polysaccharopeptide from Trametes versicolor (TPSP).
- as a CB2 antagonist along with β-caryophyllene (BCP) to study its effects on re-epithilialization of fibroblast cells.
- as a CB2 antagonist to study its interaction with 17-β-estradiol in primary human osteoblasts.
Packaging
5, 25 mg in glass bottle
Biochem/physiol Actions
AM630 is an aminoalkylindole and acts as a competitive antagonist of CP 55,940 and WIN 55,212-2. It also behaves as a competitive antagonist of anandamide and (R)-(+)-arachidonyl-1′-hydroxy-2′-propylamide (AM356).
AM630 is a selective CB2 cannabinoid antagonist/inverse agonist (Ki = 31.2 nM) with > 150-fold selectivity over CB1 receptors.
Features and Benefits
This compound is featured on the Cannabinoid Receptors page of the Handbook of Receptor Classification and Signal Transduction.
Pictograms
GHS09
Signal Word
Warning
Hazard Statements
H410
Precautionary Statements
P273 - P501
RIDADR
UN 3077 9 / PGIII
WGK Germany
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable